Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries - Journal of Obstetrics and Gynaecology Canada
Change of guidance needed for management of missed miscarriage, researchers say - The Pharmaceutical Journal
MIFEPRISTONE/MISOPROSTOL ABORTION: STEP BY STEP – EARLY ABORTION TRAINING CURRICULUM
Mifepristone - Drugs and Lactation Database (LactMed) - NCBI Bookshelf
F.D.A. Will Allow Abortion Pills by Mail During the Pandemic - The New York Times
Upcoming Changes to the Mifepristone REMS Program: Implications for Pharmacy Practice – Birth Control Pharmacist
MIFEPRISTONE: ANNIVERSARY OF FDA APPROVAL | Planned Parenthood of the Pacific Southwest, Inc.
Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity | Scientific Reports
Mifepristone 84371-65-3 | TCI AMERICA
Restrictions On Mifepristone Limit Women's Access To Miscarriage Treatment : Shots - Health News : NPR
Mifepristone (RU 486) in Cushing's syndrome in: European Journal of Endocrinology Volume 157 Issue 5 (2007)
FDA Relaxes Restrictions on Abortion Pill | MedPage Today
Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda | The National Academies Press
Progress in the bid to make abortion pills more widely available - The Boston Globe
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet